| Patent | Date |
|---|
Method of treating and preventing loss of cognition
Grant 11,452,731 - Labrie September 27, 2 | 2022-09-27 |
Pharmaceutical Compositions
App 20210069169 - LABRIE; Fernand | 2021-03-11 |
Pharmaceutical compositions
Grant 10,881,650 - Labrie January 5, 2 | 2021-01-05 |
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
Grant 10,548,903 - Labrie , et al. Fe | 2020-02-04 |
Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of sexual dysfunction in postmenopausal women
Grant 10,478,443 - El-Alfy , et al. Nov | 2019-11-19 |
Method Of Preventing Alzheimier's Disease
App 20190269696 - LABRIE; Fernand | 2019-09-05 |
A Method Of Treating And Preventing Loss Of Cognition
App 20190269697 - LABRIE; Fernand | 2019-09-05 |
Treatment of Alzheimer's disease, loss of cognition, memory loss and dementia with sex steroid precursors in combination with selective estrogen receptor modulators
Grant 10,342,805 - Labrie July 9, 2 | 2019-07-09 |
Sex Steroid Precursors Alone Or In Combination With Selective Estrogen Receptor Modulators For The Prevention And Treatment Of Sexual Dysfunction In Postmenopausal Women
App 20180271880 - EL-ALFY; Mohamed ; et al. | 2018-09-27 |
Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of dyspareunia in postmenopausal women
Grant 10,076,525 - El-Alfy , et al. September 18, 2 | 2018-09-18 |
Treatment Of Male Androgen Deficiency Symptoms Or Diseases With Sex Steroid Precursor Combined With Serm
App 20170290847 - Labrie; Fernand ; et al. | 2017-10-12 |
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
Grant 9,744,177 - Labrie , et al. August 29, 2 | 2017-08-29 |
Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
Grant 9,682,960 - Labrie , et al. June 20, 2 | 2017-06-20 |
17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
Grant 9,284,345 - Labrie , et al. March 15, 2 | 2016-03-15 |
Sex Steroid Precursors Alone Or In Combination With Selective Estrogen Receptor Modulators For The Prevention And Treatment Of Dyspareunia In Postmenopausal Women
App 20160058774 - EL-ALFY; Mohamed ; et al. | 2016-03-03 |
Treatment Of Male Androgen Deficiency Symptoms Or Diseases With Sex Steroid Precursor Combined With Serm
App 20150250802 - Labrie; Fernand ; et al. | 2015-09-10 |
Helix 12 directed pharmaceutical products
Grant 9,090,651 - Labrie , et al. July 28, 2 | 2015-07-28 |
Non-steroidal Antiandrogens And Selective Androgen Receptor Modulators With A Pyridyl Moiety
App 20150175576 - LABRIE; Fernand ; et al. | 2015-06-25 |
Pharmaceutical compositions
Grant 8,957,054 - Labrie February 17, 2 | 2015-02-17 |
Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
Grant 8,835,413 - El-Alfy , et al. September 16, 2 | 2014-09-16 |
Sexual Arousal, Sexual Desire, Orgasm And/or Pleasure Following Intravaginal Prasterone (dhea) Administration In Women Not Suffering Or Independently From Dyspareunia Or Other Symptoms Of Vulvo-vaginal Atrophy
App 20140045806 - LABRIE; Fernand | 2014-02-13 |
Pharmaceutical compositions
Grant 8,629,129 - Labrie January 14, 2 | 2014-01-14 |
Methods of treating and/or suppressing insulin resistance
Grant 8,609,695 - Labrie , et al. December 17, 2 | 2013-12-17 |
Treatment Of Alzheimer's Disease, Loss Of Cognition, Memory Loss And Dementia With Sex Steroid Precursors In Combination With Selective Estrogen Receptor Modulators
App 20130244989 - LABRIE; Fernand | 2013-09-19 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 8,389,548 - Labrie March 5, 2 | 2013-03-05 |
Pharmaceutical Compositions
App 20130005700 - LABRIE; Fernand | 2013-01-03 |
Pharmaceutical Compositions
App 20120322778 - LABRIE; Fernand | 2012-12-20 |
Pharmaceutical Compositions
App 20120283230 - LABRIE; Fernand | 2012-11-08 |
Pharmaceutical compositions
Grant 8,268,806 - Labrie September 18, 2 | 2012-09-18 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 8,188,066 - Labrie May 29, 2 | 2012-05-29 |
Helix 12 directed non-steroidal antiandrogens
Grant 8,168,627 - Labrie , et al. May 1, 2 | 2012-05-01 |
Methods Of Treating Or Preventing Estrogen-related Diseases
App 20110312925 - Labrie; Fernand | 2011-12-22 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 7,943,603 - Labrie May 17, 2 | 2011-05-17 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 7,884,092 - Labrie February 8, 2 | 2011-02-08 |
Treatment Of Hot Flushes, Vasomotor Symptoms, And Night Sweats With Sex Steroid Precursors In Combination With Selective Estrogen Receptor Modulators
App 20100317635 - LABRIE; Fernand | 2010-12-16 |
Helix 12 Directed Non-steroidal Antiandrogens
App 20100227855 - Labrie; Fernand ; et al. | 2010-09-09 |
Helix 12 directed non-steroidal antiandrogens
Grant 7,709,516 - Labrie , et al. May 4, 2 | 2010-05-04 |
Modulators of HSD17b7 for treating acne or hyperseborrhea
App 20100028879 - Labrie; Fernand ; et al. | 2010-02-04 |
Modulators of UDP-glucose ceramide glucosyltransferase for treating acne or hyperkeratinization
App 20100028878 - Labrie; Fernand ; et al. | 2010-02-04 |
Modulators of lanosterol synthetase for treating acne or hyperseborrhea
App 20100021893 - Labrie; Fernand ; et al. | 2010-01-28 |
Modulators of SC4MOL for treating acne or hyperseborrhea
App 20100021892 - Labrie; Fernand ; et al. | 2010-01-28 |
Modulators of ELOVL5 for treating acne or hyperseborrhea
App 20090298074 - Labrie; Fernand ; et al. | 2009-12-03 |
Modulators of the transporter ABCD3 for treating acne or hyperseborrhea
App 20090258356 - Labrie; Fernand ; et al. | 2009-10-15 |
Modulators of scarb-1 for treating acne or hyperseborrhea
App 20090246776 - Labrie; Fernand ; et al. | 2009-10-01 |
Pharmaceutical compositions
App 20090054383 - Labrie; Fernand | 2009-02-26 |
17alpha-substituted Steroids As Systemic Antiandrogens And Selective Androgen Receptor Modulators
App 20090042844 - LABRIE; Fernand ; et al. | 2009-02-12 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 7,429,576 - Labrie September 30, 2 | 2008-09-30 |
Pharmaceutical Compositions And Uses For Androst-5-ene-3beta, 17beta-diol
App 20080161277 - Labrie; Fernand | 2008-07-03 |
Sex steroid precursor alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
App 20070270394 - El-Alfy; Mohamed ; et al. | 2007-11-22 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
App 20070027123 - Labrie; Fernand | 2007-02-01 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
App 20070027122 - Labrie; Fernand | 2007-02-01 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
App 20070027124 - Labrie; Fernand | 2007-02-01 |
Helix 12 directed non-steroidal antiandrogens
App 20060287327 - Labrie; Fernand ; et al. | 2006-12-21 |
Use of androgens to reduce the likelihood of acquiring or to treat skin aging
App 20060178352 - El-Alfy; Mohamed ; et al. | 2006-08-10 |
Method for determination of anabolic activity
App 20060045847 - Labrie; Fernand ; et al. | 2006-03-02 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 7,005,428 - Labrie February 28, 2 | 2006-02-28 |
Pharmaceutical compositions and uses for androst-5-ene-3.beta., 17.beta.-diol
Grant 6,995,150 - Labrie February 7, 2 | 2006-02-07 |
Pharmaceutical compositions and uses for androst-5-ene-3.beta., 17.beta.-diol
Grant 6,964,955 - Labrie November 15, 2 | 2005-11-15 |
Helix 12 directed pharmaceutical products
App 20050250749 - Labrie, Fernand ; et al. | 2005-11-10 |
Antiandrogenic biphenyls
Grant 6,933,321 - Labrie , et al. August 23, 2 | 2005-08-23 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
App 20050137178 - Labrie, Fernand | 2005-06-23 |
Pharmaceutical compositions and uses for androst-5-ene-3.beta., 17.beta.-diol
Grant 6,884,795 - Labrie April 26, 2 | 2005-04-26 |
Topical antiandrogenic steroids
App 20040224935 - Labrie, Fernand ; et al. | 2004-11-11 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
App 20040157812 - Labrie, Fernand | 2004-08-12 |
Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use
App 20040082556 - Labrie, Fernand ; et al. | 2004-04-29 |
Methods of treating and/or suppressing weight gain
Grant 6,710,059 - Labrie , et al. March 23, 2 | 2004-03-23 |
Methods of treating and/or suppressing insulin resistance
App 20040034000 - Labrie, Fernand ; et al. | 2004-02-19 |
Antiandrogenic biphenyls
App 20040006134 - Labrie, Fernand ; et al. | 2004-01-08 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 6,670,346 - Labrie December 30, 2 | 2003-12-30 |
Selective estrogen receptor modulators in combination with estrogens
App 20030065008 - Labrie, Fernand | 2003-04-03 |
Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use
Grant 6,541,463 - Labrie , et al. April 1, 2 | 2003-04-01 |
Selective estrogen receptor modulators in combination with estrogens
App 20030040510 - Labrie, Fernand | 2003-02-27 |
Selective estrogen receptor modulators in combination with estrogens
App 20020198179 - Labrie, Fernand | 2002-12-26 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187962 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187969 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187966 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
App 20020187970 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187965 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187964 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187963 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
App 20020187968 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187973 - Labrie, Fernand | 2002-12-12 |
Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
App 20020187967 - Labrie, Fernand | 2002-12-12 |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
Grant 6,465,445 - Labrie October 15, 2 | 2002-10-15 |
Androgen derivatives for use in the inhibition of sex steroid activity
Grant 6,110,906 - Labrie , et al. August 29, 2 | 2000-08-29 |
Benzopyran-containing compounds and method for their use
Grant 6,060,503 - Labrie , et al. May 9, 2 | 2000-05-09 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,955,455 - Labrie September 21, 1 | 1999-09-21 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,948,434 - Labrie September 7, 1 | 1999-09-07 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,922,700 - Labrie July 13, 1 | 1999-07-13 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,872,114 - Labrie February 16, 1 | 1999-02-16 |
Controlled release systems and low dose androgens
Grant 5,861,387 - Labrie , et al. January 19, 1 | 1999-01-19 |
Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds
Grant 5,846,960 - Labrie December 8, 1 | 1998-12-08 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,843,932 - Labrie December 1, 1 | 1998-12-01 |
Sex steroid activity inhibitors
Grant 5,840,735 - Labrie , et al. November 24, 1 | 1998-11-24 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,837,700 - Labrie November 17, 1 | 1998-11-17 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,824,671 - Labrie October 20, 1 | 1998-10-20 |
Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia
Grant 5,817,649 - Labrie October 6, 1 | 1998-10-06 |
Controlled release systems and low dose androgens
Grant 5,814,340 - Labrie , et al. September 29, 1 | 1998-09-29 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,807,849 - Labrie September 15, 1 | 1998-09-15 |
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
Grant 5,776,923 - Labrie July 7, 1 | 1998-07-07 |
Low dose androgenic compounds for prevention and treatment of endometriosis
Grant 5,753,639 - Labrie May 19, 1 | 1998-05-19 |
Therapeutic methods and delivery systems utilizing sex steroid precursors
Grant 5,728,688 - Labrie March 17, 1 | 1998-03-17 |
Treatment method
Grant 5,688,769 - Labrie , et al. November 18, 1 | 1997-11-18 |
Sex steroid activity inhibitors
Grant 5,686,465 - Labrie , et al. November 11, 1 | 1997-11-11 |
Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
Grant 5,686,437 - Labrie , et al. November 11, 1 | 1997-11-11 |
Controlled release systems and low dose androgens
Grant 5,629,303 - Labrie , et al. May 13, 1 | 1997-05-13 |
Method of treatment of androgen-related diseases
Grant 5,610,150 - Labrie March 11, 1 | 1997-03-11 |
Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
Grant 5,595,985 - Labrie January 21, 1 | 1997-01-21 |
Methods for preventing and treating osteoporosis with low dose non-masculinizing androgenic compounds
Grant 5,567,695 - Labrie October 22, 1 | 1996-10-22 |
Combination therapy for the treatment of estrogen-sensitive disease
Grant 5,550,107 - Labrie August 27, 1 | 1996-08-27 |
Activation of androgen receptors with low dose non-masculinizing androgenic compounds
Grant 5,545,634 - Labrie August 13, 1 | 1996-08-13 |
Controlled release systems and low dose androgens
Grant 5,541,172 - Labrie , et al. July 30, 1 | 1996-07-30 |
Controlled release systems and low dose androgens
Grant 5,434,146 - Labrie , et al. * July 18, 1 | 1995-07-18 |
Anti-estrogenic compounds and compositions
Grant 5,395,842 - Labrie , et al. March 7, 1 | 1995-03-07 |
Therapeutic antiestrogens
Grant 5,393,785 - Labrie , et al. February 28, 1 | 1995-02-28 |
Method of treating prostate adenocarcinoma, prostate benign hypertrophia and endometriosis
Grant 5,389,613 - Labrie , et al. * February 14, 1 | 1995-02-14 |
Method of treatment of androgen-related diseases
Grant 5,372,996 - Labrie December 13, 1 | 1994-12-13 |
Inhibitors of sex steroid biosynthesis and methods for their production and use
Grant 5,364,847 - Labrie , et al. * November 15, 1 | 1994-11-15 |
Methods of treating or preventing breast or endometrial cancer with low dose non-masculinizing androgenic compounds
Grant 5,362,720 - Labrie November 8, 1 | 1994-11-08 |
Aromatase inhibitors
Grant 5,227,375 - Labrie , et al. July 13, 1 | 1993-07-13 |
Estrogen nucleus derivatives for use in inhibition of sex steroid activity
Grant 5,204,337 - Labrie , et al. April 20, 1 | 1993-04-20 |
Method of treating precocious puberty
Grant 5,189,021 - Labrie , et al. February 23, 1 | 1993-02-23 |
Combination therapy for selected sex steroid dependent cancers
Grant 5,064,813 - Labrie * November 12, 1 | 1991-11-12 |
Combination male breast cancer therapy
Grant 5,023,234 - Labrie June 11, 1 | 1991-06-11 |
Method of treating hormonal dependent mammary tumors in female mammals
Grant 4,981,842 - Labrie , et al. * January 1, 1 | 1991-01-01 |
Treatment of breast cancer by combination therapy
Grant 4,775,660 - Labrie , et al. October 4, 1 | 1988-10-04 |
Combination therapy for treatment of female breast cancer
Grant 4,775,661 - Labrie October 4, 1 | 1988-10-04 |
Combination therapy for selected sex steroid dependent cancers
Grant 4,760,053 - Labrie July 26, 1 | 1988-07-26 |
Treatment of endometriosis
Grant 4,743,589 - Labrie , et al. May 10, 1 | 1988-05-10 |
Treatment of dysmenorrhea
Grant 4,728,640 - Labrie , et al. March 1, 1 | 1988-03-01 |
Combination therapy for treatment of female breast cancer
Grant 4,666,885 - Labrie May 19, 1 | 1987-05-19 |
Method of treatment of prostate cancer
Grant 4,659,695 - Labrie April 21, 1 | 1987-04-21 |
Treatment method
Grant 4,472,382 - Labrie , et al. September 18, 1 | 1984-09-18 |
| 